文献速递垂体与肾上腺疾病

USP8基因突变对库欣病中蛋白质失调的影响

Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

结果显示USP8突变型促肾上腺皮质激素细胞腺瘤中细胞周期抑制因子p27显著降低(H-score 2.0±1.0 vs 1.1±1.1,P=0.004),pCREB升高(1.30.5±0.40.9 vs 0.70.5±0.40.7,P=0.014),HSP90表达较高但差异无统计学意义(0.5±0.4 vs 0.2±0.4,P=0.29)。结论提示USP8突变与p27/kip1、HSP90和pCREB失调相关,这些蛋白可能是USP8的直接或间接底物,并有望成为库欣病的治疗靶点。

要点

  • USP8突变型促肾上腺皮质激素细胞腺瘤中p27显著降低(P=0.004)。
  • USP8突变型腺瘤中pCREB升高(P=0.014)。
  • p27/kip1、HSP90和pCREB可能是USP8的底物及潜在治疗靶点。

核心结论

  • USP8突变与库欣病中p27/kip1、HSP90和pCREB的失调相关,这些蛋白可能是USP8的直接或间接底物,并可能成为治疗靶点。

主要发现

  • USP8突变型促肾上腺皮质激素细胞腺瘤中p27显著降低(H-score 2.0±1.0 vs 1.1±1.1,P=0.004)。
  • USP8突变型腺瘤中HSP90表达较高(0.5±0.4 vs 0.2±0.4,P=0.29)。
  • USP8突变型腺瘤中pCREB升高(1.30.5±0.40.9 vs 0.70.5±0.40.7,P=0.014)。
  • 转染USP8 P720R突变体的AtT20细胞中pCREB水平高于野生型转染细胞(1.3±0.14 vs 1±0.23,P=0.13)。

临床怎么用

  • USP8突变状态可能提示p27/kip1、HSP90和pCREB通路失调,为库欣病患者的靶向治疗提供潜在方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Cushing disease (CD) is a rare disorder with severe sequels and incompletely understood pathogenesis. The underlying corticotroph adenomas harbor frequently somatic mutations in the ubiquitin-specific peptidase 8 (USP8) gene. These mutations render USP8 hyperactive and prevent client proteins from degradation. OBJECTIVE: To investigate the impact of USP8 mutations on proteins deregulated in CD. DESIGN: One hundred eight pituitary adenomas (75 corticotroph [58 USP8 wild type (WT) and 17 USP8 mutated], 14 somatotroph, and 19 nonfunctioning) were investigated by immunohistochemistry. All evaluated proteins [USP8, arginine vasopressin receptor 1b and 2, corticotropin-releasing hormone receptor, cAMP response element-binding protein (CREB), p27/kip1, cyclin E, heat shock protein 90 (HSP90), orphan nuclear receptor 4, epidermal growth factor receptor, histone deacetylase 2, glucocorticoid receptor, cyclin-dependent kinase 5 and Abelson murine leukemia viral oncogene homolog 1 enzyme substrate 1] were known to be deregulated in CD. Furthermore, AtT20 cells were transfected with USP8 to investigate the expression of possible downstream proteins by immunoblot. RESULTS: Whereas most of the investigated proteins were not differentially expressed, the cell-cycle inhibitor p27 was significantly reduced in USP8 mutated corticotroph adenoma (H-score 2.0 ± 1.0 vs 1.1 ± 1.1 in WT adenomas; P = 0.004). In contrast, the chaperone HSP90 was expressed higher (0.5 ± 0.4 vs 0.2 ± 0.4; P = 0.29), and the phosphorylation of the transcription factor CREB was increased in USP8 mutated adenomas (1.30.5 ± 0.40.9 vs 0.70.5 ± 0.40.7; P = 0.014). Accordingly, AtT20 cells transfected with the USP8 P720R mutant had higher phosphorylated CREB (pCREB) levels than WT transfected cells (1.3 ± 0.14 vs 1 ± 0.23; P = 0.13). CONCLUSIONS: We could demonstrate that USP8 mutations are associated with deregulation of p27/kip1, HSP90, and pCREB. These findings suggest that these proteins are direct or indirect clients of USP8 and could therefore be potential targets for therapeutic approaches in patients with CD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Weigand I, Knobloch L, Flitsch J, et al. Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease. J Clin Endocrinol Metab. 2019. PMID: 30844069. doi:10.1210/jc.2018-02564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。